Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients
Authors:
- 22 June 2018
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (10) , e27281
Abstract
Background: Invasive mold infections (IMIs) are a leading cause of mortality among immunocompromised patients. Isavuconazole is a new drug that shows promise in the adult population for the treatment of IMIs. No data regarding the use of isavuconazole in pediatric patients have been published.Methods: Patients with a diagnosis of IMI from our pediatric hemato‐oncology division, treated with isavuconazole between 2010 and 2016, were identified using the hospital's computerized database. Data including demographics, clinical course, and outcome were collected. Pharmacokinetic samples were obtained from two younger patients to guide dosing.Results: In total, three patients (4.5, 5, and 19 years of age) with invasive mucormycosis who were treated with isavuconazole were identified. All patients were treated with isavuconazole as a second line therapy and experienced improvement following the initiation of this treatment.Conclusions: Based on our limited clinical experience, isavuconazole may be a safe and effective treatment option for children and adolescents afflicted by IMI. Prospective clinical trials should be performed in order to evaluate the pharmakokinetics and safety of isavuconazole in the pediatric population.Keywords
This publication has 23 references indexed in Scilit:
- Why is mucormycosis more difficult to cure than more common mycoses?Clinical Microbiology and Infection, 2014
- ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013Clinical Microbiology and Infection, 2014
- Rhinocerebral zygomycosis with pansinusitis in a 14-year-old girl with type 1 diabetes: a case report and review of the literatureItalian Journal of Pediatrics, 2013
- Risk Factors of Amphotericin B Toxicty in the Nonneonatal Pediatric PopulationThe Pediatric Infectious Disease Journal, 2012
- Rhino-Orbital-Cerebral MucormycosisCurrent Infectious Disease Reports, 2012
- Epidemiology and Clinical Manifestations of MucormycosisClinical Infectious Diseases, 2012
- How I treat mucormycosisBlood, 2011
- Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary casesMycoses, 2011
- Invasive mold infections in iatrogenically immunocompromised children: An eight‐yr reviewPediatric Transplantation, 2009
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases, 2008